Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension Due to Potential Peanut Contamination

0
12
Beef E. coli Outbreak investigation



Novartis at this time introduced a voluntary recall of three a number of Promacta (eltrombopag) 12.5 mg for oral suspension to the buyer degree. The oral suspension tons are being recalled due to a danger of potential peanut flour contamination that occurred at a third-party contract manufacturing website.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here